Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03213691 |
|---|---|
| Brief Title: | Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) |
| First Submitted : | July 10, 2017 |
| First Submitted that Met QC Criteria : | July 10, 2017 |
| First Posted : | July 11, 2017 |
| Last Update Submitted that Met QC Criteria : | December 31, 2020 |
| Last Update Posted : | January 5, 2021 |